Polymorphisms of Interleukin 1 Gene IL1RN Are Associated With Tourette Syndrome

Pediatric Neurology

Volumn 42, Issue 5, 2010, Pages 320-324

  Chou, I Ching ^a,b   Lin, Hung Chih ^a,b   Wang, Chung Hsing ^a   Lin, Wei De ^a   Lee, Cheng Chun ^a   Tsai, Chang Hai ^a,c   Tsai, Fuu Jen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; GENETIC MARKER; IL1RN PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; EXON; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; GILLES DE LA TOURETTE SYNDROME; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; CHILD; COMPARATIVE STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; PREDICTIVE VALUE; TOURETTE SYNDROME;

CHILD; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; TOURETTE SYNDROME;

EID: 77950601211     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.01.006     Document Type: Article

References (47)

1. Eldridge R., Sweet R., Lake R., Ziegler M., and Shapiro A.K. Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families. Neurology 27 (1997) 115-124
2. Price R.A., Kidd K.K., Cohen D.J., Pauls D.L., and Leckman J.F. A twin study of Tourette syndrome. Arch Gen Psychiatry 42 (1985) 815-820
3. Pauls D.L., and Leckman J.F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N Engl J Med 315 (1986) 993-997
4. Walkup J.T., LaBuda M.C., Singer H.S., Brown J., Riddle M.A., and Hurko O. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 59 (1996) 684-693
5. Seuchter S.A., Hebebrand J., Klug B., et al. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genet Epidemiol 18 (2000) 33-47
6. Barr C.L., Wigg K.G., Pakstis A.J., et al. Genome scan for linkage to Gilles de la Tourette syndrome. Am J Med Genet 88 (1999) 437-445
7. Tourette Syndrome Association International Consortium for Genetics. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 65 (1999) 1428-1436
8. Kiessling L.S., Marcotte A.C., and Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 92 (1993) 39-43
9. Swedo S.E., Leonard H.L., Garvey M., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases [Erratum in: Am J Psychiatry 1998;155:578]. Am J Psychiatry 155 (1998) 264-271
10. Cardona F., and Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 138 (2001) 71-75
11. Church A.J., Dale R.C., Lees A.J., Giovannoni G., and Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74 (2003) 602-607
12. Murphy M.L., and Pichichero M.E. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 156 (2002) 356-361
13. Luo F., Leckman J.F., Katsovich L., et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 113 (2004) e578-e585
14. Murphy T.K., Sajid M., Soto O., et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry 55 (2004) 61-68
15. Smagin G.N., Swiergiel A.H., and Dunn A.J. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology 21 (1996) 83-93
16. Wieczorek M., and Dunn A.J. Relationships among the behavioral, noradrenergic, and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin. Brain Behav Immun 20 (2006) 477-487
17. Chou I.C., Tsai C.H., Lee C.C., et al. Association analysis between Tourette's syndrome and dopamine D1 receptor gene in Taiwanese children. Psychiatr Genet 14 (2004) 219-221
18. Lee C.C., Chou I.C., Tsai C.H., Wang T.R., Li T.C., and Tsai F.J. Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr Neurol 33 (2005) 272-276
19. Chou I.C., Tsai C.H., Wan L., Hsu Y.A., and Tsai F.J. Association study between Tourette's syndrome and polymorphisms of noradrenergic genes (ADRA2A, ADRA2C). Psychiatr Genet 17 (2007) 359
20. American Psychiatric Association, and Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed., text revision (2000), American Psychiatric Association, Washington, DC
21. Pociot F., Mølvig J., Wogensen L., Worsaae H., and Nerup J. A Taq 1 polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 22 (1992) 396-402
22. di Giovine F.S., Takhsh E., Blakemore A.I., and Duff G.W. Single base polymorphism at -511 in the human interleukin-1β gene (IL-1β). Hum Mol Genet 1 (1992) 450
23. Garcia-Velasco J.A., and Arici A. Chemokines and human reproduction. Fertil Steril 71 (1999) 983-993
24. Dinarello C.A. Interleukin-1. Rev Infect Dis 6 (1984) 51-95
25. Peterson B.S., Skudlarski P., Anderson A.W., et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 55 (1998) 326-333
26. Steeves T.D., and Gox S.H. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 172 (2008) 495-513
27. Lee C.C., Chou I.C., Tsai C.H., Wang T.R., Li T.C., and Tsai F.J. Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr Neurol 33 (2005) 272-276
28. Licastro F., Pedrini S., Ferri C., et al. Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol 48 (2000) 388-391
29. Nishimura M., Mizuta I., Mizuta E., Yamasaki S., Ohta M., and Kuno S. Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease. Neurosci Lett 284 (2000) 73-76
30. Katila H., Hänninen K., and Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4 (1999) 179-181
31. Son K., Tomita Y., Shimizu T., Nishinarita S., Sawada S., and Horie T. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Intern Med 39 (2000) 128-135
32. Kantarci O.H., Atkinson E.J., Hebrink D.D., McMurray C.T., and Weinshenker B.G. Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol 106 (2000) 220-227
33. Hulkkonen J., Vilpo J., Vilpo L., Koski T., and Hurme M. Interleukin-1β, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85 (2000) 600-606
34. Dewberry R., Holden H., Crossman D., and Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) 2394-2400
35. Francis S.E., Camp N.J., Dewberry R.M., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99 (1999) 861-866
36. Takamatsu M., Yamauchi M., Maezawa Y., Saito S., Maeyama S., and Uchikoshi T. Genetic polymorphisms of interleukin-1β in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 95 (2000) 1305-1311
37. Smithies A.M., Sargen K., Demaine A.G., and Kingsnorth A.N. Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis. Pancreas 20 (2000) 234-240
38. Nemetz A., Kope A., Molnar T., et al. Significant differences in the interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J Gastroenterol 34 (1999) 175-179
39. Shu K.H., Lee S.H., Cheng C.H., Wu M.J., and Lian J.D. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy. Kidney Int 58 (2000) 783-789
40. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 28 (1998) 2598-2602
41. Mori H., Sawairi M., Nakagawa M., Itoh N., Wada K., and Tamaya T. Expression of interleukin-1 (IL-1) β messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis. Fertil Steril 57 (1992) 535-542
42. *2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 47 (1998) 195-198
43. Blakemore A.I., Tarlow J.K., Cork M.J., Gordon C., Emery P., and Duff G.W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37 (1994) 1380-1385
44. Tarlow J.K., Cork M.J., Clay F.E., et al. Association between interleukin-1 receptor antagonist (IL-1Ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 136 (1997) 147-148
45. Tarlow J.K., Clay F.E., Cork M.J., et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 103 (1994) 387-390
46. Clay F.E., Cork M.J., Tarlow J.K., et al. Interleukin-1 receptor antagonist gene polymorphism associated with lichen sclerosus. Hum Genet 94 (1994) 407-410
47. Mansfield J.C., Holden H., Tarlow J.K., et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106 (1994) 637-642